Cargando…

The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on (131)I-SPECT/CT

BACKGROUND: To explore the (131)I-SPECT/CT characteristics of remnant thyroid tissue (RTT) in differentiated thyroid cancer (DTC), further assess the risk factors and clinical significance. METHODS: 52 DTC patients after total thyroidectomy had undergone neck (131)I-SPECT/CT before (131)I ablation....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Feng, Nie, Hui, Li, Wei, Zhang, Rusen, Li, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105984/ https://www.ncbi.nlm.nih.gov/pubmed/33964885 http://dx.doi.org/10.1186/s12880-021-00612-5

Ejemplares similares

A Neck-Thyroid Phantom with Small Sizes of Thyroid Remnants for Postsurgical I-123 and I-131 SPECT/CT Imaging
por: Michael, Konstantinos, et al.
Publicado: (2023)

The Diagnostic Usefulness of (131)I-SPECT/CT at Both Radioiodine Ablation and during Long-Term Follow-Up in Patients Thyroidectomized for Differentiated Thyroid Carcinoma: Analysis of Tissue Risk Factors Ascertained at Surgery and Correlated with Metastasis Appearance
por: Spanu, Angela, et al.
Publicado: (2021)

In Thyroidectomized Thyroid Cancer Patients, False-Positive I-131 Whole Body Scans Are Often Caused by Inflammation Rather Than Thyroid Cancer
por: Garger, Yana Basis, et al.
Publicado: (2016)

Efficacy and Affecting Factors of (131)I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
por: Wang, Chen, et al.
Publicado: (2018)

Frequency of thyroid nodules and thyroid cancer in thyroidectomized patients with Graves’ disease
por: Keskin, Caglar, et al.
Publicado: (2019)

TRANSFER OF EXPERIMENTAL AUTOIMMUNE THYROIDITIS BY SERUM FROM THYROIDECTOMIZED DONORS
por: Nakamura, R. M., et al.
Publicado: (1969)

False Positive Findings on I-131 WBS and SPECT/CT in Patients with History of Thyroid Cancer: Case Series
por: Hannoush, Zeina C., et al.
Publicado: (2017)

I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
por: Lin, Rong, et al.
Publicado: (2015)

I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence
por: Shengguang, Yan, et al.
Publicado: (2016)

A false-positive I-131 finding of duodenum diverticulum in thyroid cancer evaluation by SPECT/CT: A case report
por: Wang, Rang, et al.
Publicado: (2018)

MON-443 SPECT/CT Localization of Incidental Diverticular Bleed After Radioiodine (i(131)) Therapy for Metastatic Thyroid Cancer
por: Doshi, Sejal B, et al.
Publicado: (2020)

TSH ≥30 mU/L may not be necessary for successful (131)I remnant ablation in patients with differentiated thyroid cancer
por: Ju, Nianting, et al.
Publicado: (2023)

Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter
por: Fama, Fausto, et al.
Publicado: (2018)

Effect of (131)I ‘clear residual thyroid tissue’ after surgery on the function of parathyroid gland in differentiated thyroid cancer
por: ZHAO, ZHI-HUA, et al.
Publicado: (2015)

Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a (131)I-SPECT/CT study
por: Spanu, Angela, et al.
Publicado: (2020)

Clinical experience following implementation of routine SPECT-CT imaging following 131-iodine administration for thyroid cancer
por: Ahmadi, Sara, et al.
Publicado: (2022)

Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with (131)I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
por: Signore, Alberto, et al.
Publicado: (2022)

Hybrid SPECT/CT Imaging in the Management of Differentiated Thyroid Carcinoma
por: Ahmed, Najeeb, et al.
Publicado: (2018)

Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan Is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer
por: Jia, Xi, et al.
Publicado: (2022)

Body Mass Index Is Associated with Hypercholesterolemia following Thyroid Hormone Withdrawal in Thyroidectomized Patients
por: Shin, Dong Yeob, et al.
Publicado: (2014)

Breast cancer in previously thyroidectomized patients: which thyroid disorders are a risk factor?
por: Graceffa, Giuseppa, et al.
Publicado: (2021)

Impact of thyroiditis on (131)I uptake during ablative therapy for differentiated thyroid cancer
por: Lim, Eugenie S, et al.
Publicado: (2019)

Thyroid Remnant Estimation by Diagnostic Dose (131) I Scintigraphy or (99m) T c O (4) (−) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131) I Imaging
por: Liu, Guanghui, et al.
Publicado: (2016)

Ectopic Thyroid Tissue in the Mediastinum Characterized by Histology and Functional Imaging with I-123 SPECT/CT
por: Hummel, Jed, et al.
Publicado: (2017)

Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study
por: Mester, Alexandru, et al.
Publicado: (2020)

Clinical Value of (99m)Tc-3PRGD2 SPECT/CT in Differentiated Thyroid Carcinoma with Negative (131)I Whole-Body Scan and Elevated Thyroglobulin Level
por: Gao, Rui, et al.
Publicado: (2018)

Carcinogenesis in the Thyroidectomized Rat
por: Bielschowsky, F., et al.
Publicado: (1953)

Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma
por: Bhattacharya, Anish, et al.
Publicado: (2010)

Intrathoracic stomach mimicking bone metastasis from thyroid cancer in whole-body iodine-131 scan diagnosed by SPECT/CT
por: García-Gómez, Francisco Javier, et al.
Publicado: (2017)

Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy
por: Zubair Hussain, Syed, et al.
Publicado: (2014)

I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy
por: Probst, Stephan, et al.
Publicado: (2018)

Rate of thyroglossal duct remnant visualization after total thyroidectomy for differentiated thyroid carcinoma and its impact on clinical outcome of radioactive iodine (I-131) ablation
por: Mohamed Sayed, Mohamed Hosny, et al.
Publicado: (2015)

SYNTHESIS OF SULFOMUCOPOLYSACCHARIDES IN THYROIDECTOMIZED RATS
por: Dziewiatkowski, Dominic D.
Publicado: (1957)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma
por: Oral, Aylin, et al.
Publicado: (2018)

Thyroid hormone replacement one day before (131)I therapy in patients with well-differentiated thyroid cancer
por: Kayano, Daiki, et al.
Publicado: (2013)

Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer
por: Lee, Chang-Hee, et al.
Publicado: (2018)

Induction of Leukaemia by (131)I Treatment of Thyroid Carcinoma
por: Brincker, H., et al.
Publicado: (1973)

Increased Thyroid-Hormone Requirements Consistent With Type 3 Deiodinase Induction Related to Ibrutinib in a Thyroidectomized Woman
por: Mazori, Alon Yehuda, et al.
Publicado: (2020)

Findings of I-131 SPECT/CT, (18)F-FDG, and (68)Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma
por: Tatar, Gamze, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kom83t0ecsfohkd67vpkogpvna